At a glance
ClinicalIndex Comparison RecordN/ACompleted· 39 enrolled
Drug / intervention
Surgical Ablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Outcomes of Surgical AF Ablation Using cryoICE Cryoablation System
In Brief
An observational study evaluating Surgical Ablation for Atrial Fibrillation and Atrial Flutter. Completed, enrolled 39 participants across 6 sites.
Detailed Summary
This study is proposed herein is to gather clinical data on the safety and performance of the CRYOF device.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Atrial Flutter
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedOct 2021
Enrollment StartApr 2022
Primary CompletionMar 2023
Study CompletionDec 2023
TodayJul 2026
First PostedOct 22, 2021
Enrollment StartApr 29, 2022
Primary CompletionMar 31, 2023
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.7 years ago
Interventions
Surgical Ablationdevice
The AtriCure cryoICE® cryoFORMTM cryoablation probe is used in the cryosurgical treatment of cardiac arrhythmias by freezing target tissues, creating an inflammatory response (cryonecrosis) that blocks the electrical conduction pathway.